The global Adipose-derived Stem Cell Market size is expected to reach USD 2.34 billion by 2025, according to a new report by Emergen Research, growing at a CAGR of 18.3% over the forecast period.
The global Adipose-derived Stem Cell Market size is expected to reach USD 2.34 billion by 2025, according to a new report by Emergen Research, growing at a CAGR of 18.3% over the forecast period. This can be attributed to the many advantages offered by these cells, such as their ability to self-renew and differentiate into various cell types. In addition, these cells are easily accessible and can be isolated from liposuctioned fat tissue. Moreover, adipose-derived stem cells have a high proliferation potential and can be expanded in vitro.
The rising demand for minimally invasive cosmetic procedures is anticipated to fuel market growth over the forecast period. Various applications of these cells have been approved by the FDA, which is projected to increase adoption. For instance, in 2020, the agency approved fat grafting for breast augmentation procedures.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/203
These cells are being increasingly used in the treatment of cardiovascular diseases. They help in reducing infarct size and improve cardiac function post-myocardial infarction (MI). In addition, rising prevalence of chronic diseases is expected to propel market demand.
The increasing awareness regarding the therapeutic potential of these cells is projected to drive the market over the forecast period. Moreover, initiatives by public and private organizations are anticipated to create growth opportunities for industry players. For instance, in February 2019, Mesoblast Limited received U.S. FDA approval for its product MPC-150-IM to treat steroid-refractory acute graft versus host disease (SR-aGVHD).
Some Key Highlights From the Report
- Key companies in the market include Allocure, Inc., Celgene Corporation, Pluristem Therapeutics, Inc., Intrexon, Inc., Celleris SA, Tissue Genesis, Inc., Mesoblast, Ltd., Antaria, Inc. Thermo Fisher Scientific, Inc., American CryoStem, and Merck KGaA.
- In September 2021, BioRestorative Therapies, Inc. announced that it had received a patent for the use of adipose-derived stem cells (ADSCs) to treat Huntington’s disease. This new patent, which was issued by the United States Patent and Trademark Office, covers the method of isolating ADSCs from human fat tissue and the delivery of these cells to the brain for the treatment of Huntington’s disease.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/adipose-derived-stem-cell-market
- On the basis of product, the adipose-derived stem cell market is classified into cell lines, primary cells, and media. The primary cells segment accounted for the largest share of the global market in 2020. Primary cells are derived directly from an individual patient and are not expanded or subcultured. These are used in research studies to understand the development of a disease and its progression. The cell lines segment is expected to grow at the highest CAGR during the forecast period. Cell lines are an immortalized population of cells that can be subcultured indefinitely and used for various applications.
- Based on application, the adipose-derived stem cell market is segmented into regenerative medicine, drug discovery and development, and research. The regenerative medicine segment is further subsegmented into orthopedic, cardiovascular, skin and wound healing, and others. The drug discovery and development application segment includes target identification/validation, lead optimization, hit to lead, and preclinical studies. The research application segment is expected to grow at the highest CAGR during the forecast period. The use of adipose-derived stem cells in research is expected to increase due to the rising number of research studies being conducted on these cells.
- The global adipose-derived stem cell market is segmented based on end user into hospitals, academic and research institutes, and contract research organizations (CROs). The hospitals segment is expected to grow at the highest CAGR during the forecast period. The growth of this end-user segment can be attributed to the increasing number of procedures being performed in hospitals, as well as the rising number of hospitals adopting adipose-derived stem cell therapy.
- In terms of geography, the global adipose-derived stem cell market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global market in 2020. The large share of this region can be attributed to factors such as the favorable reimbursement scenario and government support for stem cell research in the US, and the presence of a large number of key market players in this region.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/203
For the purpose of this report, Emergen Research has segmented the global adipose-derived stem cell market on the basis of cell type, product type, disease indication, end-use industries, application, and region:
Cell Type Outlook (Revenue, USD Billion; 2018–2028)
- Allogenic
- Autologous
Product Type Outlook (Revenue, USD Billion; 2018–2028)
- Cell Line
- Culture Media
- Media
- Sera
- Reagents
Disease Indication Outlook (Revenue, USD Billion; 2018–2028)
- Cancer
- Obesity
- Wounds & Injuries
- Cardiovascular Diseases
- Musculoskeletal
End-use Industries Outlook (Revenue, USD Billion; 2018–2028)
- Cell Banks & Tissue Banks
- Research Laboratories & Academic Institutes
- Hospitals & Trauma Centers
- Others
Application Outlook (Revenue, USD Billion; 2018–2028)
- Therapeutic
- Research
- Others
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Israel
- Rest of MEA
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/203
Explore More Reports Emergen Research:
High-Performance Computing Market
Interventional Oncology Devices Market
Air Quality Monitoring System Market
Autoclaved Aerated Concrete Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Published Titles Smart Cities Market | Smart Learning Market
Trending Titles Humanoid Robot Market | Incident Response Market